skip to main content

Marfan Syndrome, A Review

VU University Medical Center, Netherlands

Received: 7 Nov 2018; Published: 31 Dec 2018.
Open Access Copyright (c) 2018 Journal of Biomedicine and Translational Research

Citation Format:

Marfan syndrome is named after the French pediatrician Antoine Bernard-Jean Marfan who described in 1896 a girl with arachnodactyly and long limbs1. The patient also had congenital contractures of the elbows and would not fulfill the current criteria for Marfan syndrome. She probably was suffering from a condition that we now call contractural arachnodactyly, caused by mutations in the FBN2 gene.

The clinical features of Marfan syndrome affect many systems of the body. The most obvious are the skeletal features, long limbs, tall stature, long thin fingers (arachnodactyly or spider fingers). The skeletal features can be scored objectively as: arm span more than 1.05 x body length; wrist sign (thumb and index finger can encircle the wrist of the other hand with at least one digit overlap) and thumb sign (when making a fist around the thumb, one digit of the thumb sticks out). The main neurological symptom is dural ectasias. The most severe symptoms are cardiovascular: mitralis valve prolapse, aortic dilatation and thoracic aortic aneurysms and dissections, which may lead to sudden death5. However, I noticed in discussions with patients that they often consider the ocular symptoms, severe myopia and lens luxation, the worst for themselves, because the latter may lead to blindness.
Fulltext View|Download
Keywords: Marfan syndrome; FBN1; aortic aneurysm, losartan

Article Metrics:

  1. Marfan, AB. Un cas de déformation congénitale des quartre membres, plus prononcée aux extrémitiés, caractérisée par l'allongement des os avec un certain degré d'amincissement. Bulletins et memoires de la Société medicale des hôspitaux de Paris. 1896;13 (3rd series): 220–226
  2. Groth KA, Stochholm K, Hove H, Andersen NH, Gravholt CH. Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study). Am J Cardiol. 2018 Oct 1;122(7):1231-1235. doi: 10.1016/j.amjcard.2018.06.034.Epub2018Jul21
  3. Ergoren MC, Turkgenc B, Terali K, Rodoplu O, Verstraeten A, Van Laer L, Mocan G, Loeys B, Tetik O, Temel SG. Identification and characterization of a novel FBN1 gene variant in an extended family with variable clinical phenotype of Marfan syndrome. Connect Tissue Res. 2018 May 28:1-9. doi: 10.1080/03008207.2018.1472589.[Epubaheadofprint]
  4. Aalberts JJ, Schuurman AG, Pals G, Hamel BJ, Bosman G, Hilhorst-Hofstee Y, Barge-Schaapveld DQ, Mulder BJ, van den Berg MP, van Tintelen JP. Recurrent and founder mutations in the Netherlands: Extensive clinical variability in Marfan syndrome patients with a single novel recurrent fibrillin-1 missense mutation. Neth Heart J. 2010 Feb;18(2):85-9
  5. Li Y, Xu J, Chen M, Du B, Li Q, Xing Q, Zhang Y. A FBN1 mutation association with different phenotypes of Marfan syndrome in a Chinese family. Clin Chim Acta. 2016 Sep 1;460:102-6. doi: 10.1016/j.cca.2016.06.031.Epub2016Jun25
  6. Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister DW, Horton W, McKusick VA, Opitz JM, Pope FM, Pyeritz RE, Rimoin DL, Sillence D, Spranger JW, Thompson E, Tsipouras P, Viljoen D, Winship I, Young James I, Reynolds F. International nosology of heritable disorders of connective tissue, Berlin, 1986. Am J Med Genet. 1988 Mar;29(3):581-94. doi: 10.1002/ajmg.1320290316
  7. De Paepe A1, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996 Apr 24;62(4):417-26. doi: 10.1136/jmg.2009.072785
  8. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010 Jul;47(7):476-85. doi: 10.1136/jmg.2009.072785
  9. Attanasio M, Pratelli E, Porciani MC, Evangelisti L, Torricelli E, Pellicanò G, Abbate R, Gensini GF, Pepe G. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis. Eur J Med Genet. 2013 Jul;56(7):356-60. doi: 10.1016/j.ejmg.2013.04.006.Epub2013May15
  10. Franken R, den Hartog AW, van de Riet L, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, Zwinderman AH, Groenink M, Yip JW, Mulder BJ. Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome. Circ J. 2013;77(11):2793-8. Epub 2013 Aug 29
  11. Yoo EH, Woo H, Ki CS, Lee HJ, Kim DK, Kang IS, Park P, Sung K, Lee CS, Chung TY, Moon JR, Han H, Lee ST, Kim JW. Clinical and genetic analysis of Korean patients with Marfan syndrome: possible ethnic differences in clinical manifestation. Clin Genet. 2010 Feb;77(2):177-82. doi: 10.1111/j.1399-0004.2009.01287.x.Epub2009Oct23.Erratumin:ClinGenet.2010Nov;78(5):505.doi: 10.1111/j.1399-0004.2009.01287.x. Epub 2009 Oct 23. Erratum in: Clin Genet. 2010 Nov;78(5):505.
  12. Faivre L, Collod-Beroud G, Callewaert B, Child A, Loeys BL, Binquet C, Gautier E, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Grasso M, Beroud C, Bonithon-Kopp C, Claustres M, Stheneur C, Bouchot O, Wolf JE, Robinson PN, Adès L, De Backer J, Coucke P, Francke U, De Paepe A, Boileau C, Jondeau G. Pathogenic FBN1 mutations in 146 adults not meeting clinical diagnostic criteria for Marfan syndrome: further delineation of type 1 fibrillinopathies and focus on patients with an isolated major criterion. Am J Med Genet A. 2009 May;149A(5):854-60 doi: 10.1002/ajmg.a.32809
  13. Dietz HC Cutting GR Pyeritz RE . Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. . Nature . 1991;352:337–339. doi: 10.1038/352337a0
  14. Loeys B, De Backer J, Van Acker P, Wettinck K, Pals G, Nuytinck L, Coucke P, De Paepe A. Comprehensive molecular screening of the FBN1 gene favors locus homogeneity of classical Marfan syndrome. Hum Mutat. 2004 Aug;24(2):140-6. doi: 10.1002/humu.20070
  15. Teixeira LV, Lezirovitz K, Pereira LV, Perez AB. Candidate gene linkage analysis indicates genetic heterogeneity in Marfan syndrome. Braz J Med Biol Res. 2011 Aug;44(8):793-800
  16. Groth KA, Hove H, Kyhl K, Folkestad L, Gaustadnes M, Vejlstrup N, Stochholm K, Østergaard JR, Andersen NH, Gravholt CH. Prevalence, incidence, and age at diagnosis in Marfan Syndrome. Orphanet J Rare Dis. 2015 Dec 2;10:153. doi: 10.1186/s13023-015-0369-8
  17. Penpattharakul W, Pithukpakorn M. Revised Ghent Criteria is Comparable to Original Diagnostic Criteria for Marfan Syndrome with Increased Ability to Clinically Diagnose Related Disorders. J Med Assoc Thai. 2016 Jan;99(1):34-9
  18. de Vries BB, Pals G, Odink R, Hamel BC. Homozygosity for a FBN1 missense mutation: clinical and molecular evidence for recessive Marfan syndrome. Eur J Hum Genet. 2007 Sep;15(9):930-5. doi: 10.1038/sj.ejhg.5201865
  19. Van Dijk FS, Hamel BC, Hilhorst-Hofstee Y, Mulder BJ, Timmermans J, Pals G, Cobben JM. Compound-heterozygous Marfan syndrome. Eur J Med Genet. 2009 Jan-Feb;52(1):1-5. doi: 10.1016/j.ejmg.2008.11.004.Epub2008Nov27
  20. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem. 2003 Jan 24;278(4):2750-7. doi: 10.1074/jbc.M209256200
  21. Davis MR1, Summers KM. Structure and function of the mammalian fibrillin gene family: implications for human connective tissue diseases. Mol Genet Metab. 2012 Dec;107(4):635-47. doi: 10.1016/j.ymgme.2012.07.023.Epub2012Aug3
  22. Hubmacher D, Apte SS. ADAMTS proteins as modulators of microfibril formation and function. Matrix Biol. 2015 Sep;47:34-43. doi: 10.1016/j.matbio.2015.05.004.Epub2015May7
  23. Gabriel LA Wang LW Bader H. ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis. Invest Ophthalmol Vis Sci . 2012;53:461–469. doi: 10.1167/iovs.10-5955
  24. Beroud C Collod-Beroud G Boileau C Soussi T Junien C. UMD (Universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat . 2000;15:86–94. doi: 10.1002/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4
  25. Hilhorst-Hofstee Y, Hamel BC, Verheij JB, Rijlaarsdam ME, Mancini GM, Cobben JM, Giroth C, Ruivenkamp CA, Hansson KB, Timmermans J, Moll HA, Breuning MH, Pals G. The clinical spectrum of complete FBN1 allele deletions. Eur J Hum Genet. 2011 Mar;19(3):247-52. doi: 10.1038/ejhg.2010.174.Epub2010Nov10
  26. Furtado LV, Wooderchak-Donahue W, Rope AF, Yetman AT, Lewis T, Plant P, Bayrak-Toydemir P. Characterization of large genomic deletions in the FBN1 gene using multiplex ligation-dependent probe amplification. BMC Med Genet. 2011 Sep 21;12:119. doi: 10.1186/1471-2350-12-119
  27. Mátyás G, Alonso S, Patrignani A, Marti M, Arnold E, Magyar I, Henggeler C, Carrel T, Steinmann B, Berger W. Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome. Hum Genet. 2007 Aug;122(1):23-32. doi: 10.1007/s00439-007-0371-x
  28. Yang H, Ma Y, Luo M, Zhao K, Zhang Y, Zhu G, Sun X, Luo F, Wang L, Shu C, Zhou Z. Identification of gross deletions in FBN1 gene by MLPA. Hum Genomics. 2018 Oct 4;12(1):46. doi: 10.1186/s40246-018-0178-y
  29. Dordoni C, Ciaccio C, Santoro G, Venturini M, Cavallari U, Ritelli M, Colombi M. Marfan syndrome: Report of a complex phenotype due to a 15q21.1 contiguos gene deletion encompassing FBN1, and literature review. Am J Med Genet A. 2017 Jan;173(1):200-206. doi: 10.1002/ajmg.a.37975.Epub2016Sep12
  30. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002 Jun 15;30(12):e57
  31. Knott V, Downing AK, Cardy CM, Handford P. Calcium binding properties of an epidermal growth factor-like domain pair from human fibrillin-1. J Mol Biol. 1996 Jan 12;255(1):22-7
  32. iCn3D [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. 2016 – available from:
  34. Hilhorst-Hofstee Y, Rijlaarsdam ME, Scholte AJ, Swart-van den Berg M, Versteegh MI, van der Schoot-van Velzen I, Schäbitz HJ, Bijlsma EK, Baars MJ, Kerstjens-Frederikse WS, Giltay JC, Hamel BC, Breuning MH, Pals G. The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family. Hum Mutat. 2010 Dec;31(12):E1915-27. doi: 10.1002/humu.21372
  35. Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans . doi: 10.1038/nature19057
  36. Bresters D, Nikkels PG, Meijboom EJ, Hoorntje TM, Pals G, Beemer FA. Clinical, pathological and molecular genetic findings in a case of neonatal Marfan syndrome. Acta Paediatr. 1999 Jan;88(1):98-101
  37. ter Heide H, Schrander-Stumpel CT, Pals G, Delhaas T. Neonatal Marfan syndrome: clinical report and review of the literature. Clin Dysmorphol. 2005 Apr;14(2):81-4
  38. Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med. 2015 Mar;17(3):177-87. doi: 10.1038/gim.2014.91.Epub2014Aug7
  39. den Hartog AW, Franken R, Zwinderman AH, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, Pals G, Mulder BJ, Groenink M. The risk for type B aortic dissection in Marfan syndrome. J Am Coll Cardiol. 2015 Jan 27;65(3):246-54. doi: 10.1016/j.jacc.2014.10.050
  40. Franken R, Groenink M, de Waard V, Feenstra HM, Scholte AJ, van den Berg MP, Pals G, Zwinderman AH, Timmermans J, Mulder BJ. Genotype impacts survival in Marfan syndrome. Eur Heart J. 2016 Nov 14;37(43):3285-3290. doi: 10.1093/eurheartj/ehv739
  41. Franken R, Teixido-Tura G, Brion M, Forteza A, Rodriguez-Palomares J, Gutierrez L, Garcia Dorado D, Pals G, Mulder BJ, Evangelista A. Relationship between fibrillin-1 genotype and severity of cardiovascular involvement in Marfan syndrome. Heart. 2017 Nov;103(22):1795-1799. doi: 10.1136/heartjnl-2016-310631.Epub2017May3
  42. den Hartog AW, Franken R, van den Berg MP, Zwinderman AH, Timmermans J, Scholte AJ, de Waard V, Spijkerboer AM, Pals G, Mulder BJ, Groenink M. The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations. Neth Heart J. 2016 Nov;24(11):675-681. doi: 10.1007/s12471-016-0905-8
  43. Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, Meijers-Heijboer HE, Timmermans J, Scholte AJ, van den Berg MP, Groenink M, Mulder BJ, Zwinderman AH, de Waard V, Pals G. Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome. Circ Cardiovasc Genet. 2015 Apr;8(2):383-8. doi: 10.1161/CIRCGENETICS.114.000950.Epub2015Jan22
  44. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006 Apr 7;312(5770):117-21.DOI: 10.1126/science.1124287
  45. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005 Mar;37(3):275-81DOI: 10.1038/ng1511
  46. Akhurst RJ. The paradoxical TGF-ß vasculopathies. Nat Genet. 2012 Jul 27;44(8):838-9.DOI: 10.1038/ng.2366
  47. Loeys BL. Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?. Drug Discov Today. 2015 Feb;20(2):262-6. DOI: 10.1016/j.drudis.2014.09.022
  48. Franken R, Radonic T, den Hartog AW, Groenink M, Pals G, van Eijk M, Lutter R, Mulder BJ, Zwinderman AH, de Waard V; COMPARE study group.. The revised role of TGF-ß in aortic aneurysms in Marfan syndrome. Neth Heart J. 2015 Feb;23(2):116-21 doi: 10.1007/s12471-014-0622-0
  49. van Dijk FS, Meijers-Heijboer H, Pals G. Angiotensin II blockade in Marfan's syndrome. N Engl J Med. 2008 Oct 16;359(16):1733
  50. Radonic T, de Witte P, Groenink M, de Waard V, Lutter R, van Eijk M, Jansen M, Timmermans J, Kempers M, Scholte AJ, Hilhorst-Hofstee Y, van den Berg MP, van Tintelen JP, Pals G, Baars MJ, Mulder BJ, Zwinderman AH. Inflammation aggravates disease severity in Marfan syndrome patients. PLoS One. 2012;7(3):e32963. doi: 10.1371/journal.pone.0032963.Epub2012Mar30
  51. Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, Scholte AJ, van den Berg MP, Spijkerboer AM, Marquering HA, Zwinderman AH, Mulder BJ. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J. 2013 Dec;34(45):3491-500doi: 10.1093/eurheartj/eht334.Epub2013Sep2
  52. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, Pearson GD, Selamet Tierney ES, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Wechsler SB, Young LT, Mahony L; Pediatric Heart Network Investigators. Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med. 2014 Nov 27;371(22):2061-71.doi: 10.1056/NEJMoa1404731.Epub2014Nov18
  53. Milleron O, Arnoult F, Ropers J, Aegerter P, Detaint D, Delorme G, Attias D, Tubach F, Dupuis-Girod S, Plauchu H, Barthelet M, Sassolas F, Pangaud N, Naudion S, Thomas-Chabaneix J, Dulac Y, Edouard T, Wolf JE, Faivre L, Odent S, Basquin A, Habib G, Collignon P15, Boileau C16, Jondeau G17. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur Heart J. 2015 Aug 21;36(32):2160-6.doi: 10.1093/eurheartj/ehv151.Epub2015May2
  54. Teixido-Tura G, Forteza A, Rodríguez-Palomares J, González Mirelis J, Gutiérrez L, Sánchez V, Ibáñez B, García-Dorado D, Evangelista A. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome. J Am Coll Cardiol. 2018 Oct 2;72(14):1613-1618doi: 10.1016/j.jacc.2018.07.052
  55. Gao L, Chen L, Fan L, Gao D, Liang Z, Wang R, Lu W. The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials. Int J Cardiol. 2016 Aug 15;217:190-4. doi: 10.1016/j.ijcard.2016.04.186.Epub2016May4

Last update: 2021-08-05 18:10:57

No citation recorded.

Last update: 2021-08-05 18:10:57

  1. Obstetric and cardiac outcomes in women with Marfan syndrome and an aortic root diameter ≤ 45mm

    Minsart A.F.. European Journal of Obstetrics and Gynecology and Reproductive Biology, 127 , 2018. doi: 10.1016/j.ejogrb.2018.09.012
  2. Cardiovascular anomalies in marfan’s syndrome: The role of echocardiography and β-blockers

    Tahernia A.. Southern Medical Journal, 86 (3), 1993. doi: 10.1097/00007611-199303000-00012
  3. Application of cook balloon during aorta replacement in a pregnant Marfan-syndrome patient: A case report

    Zhang L.. BMC Pregnancy and Childbirth, 20 (1), 2020. doi: 10.1186/s12884-020-02871-6
  4. Prevalence of concomitant hypo-hyperdontia in a group of Turkish orthodontic patients

    Gokkaya B.. European Archives of Paediatric Dentistry, 17 (1), 2016. doi: 10.1007/s40368-015-0201-0
  5. "Like mother, like son:" Hereditary anterior sacral meningocele - Case report and review of the literature

    Gardner P.. Journal of Neurosurgery, 104 , 2006.
  6. Distribution of hypodontia and hyperdontia in concomitant hypo-hyperdontia patients: Critical appraisal of the published data

    Chen Y.. European Journal of General Dentistry, 6 (1), 2017. doi: 10.4103/2278-9626.198622
  7. Pre-maxillary hypo-hyperdontia: Report of a rare case

    Nirmala S.. Romanian Journal of Morphology and Embryology, 54 (2), 2013.
  8. Aneurysms and dissections: What is new in the literature of 2019/2020

    Nikol S.. Vasa - European Journal of Vascular Medicine, 49 , 2020. doi: 10.1024/0301-1526/a000865
  9. Factors leading to lateral ankle Sprain: A review of the literature

    Raina S.. Journal of Musculoskeletal Research, 17 (4), 2014. doi: 10.1142/S0218957714300014
  10. Marfan's syndrome: A review

    Aburawi E.. Hospital Medicine, 62 (3), 2001. doi: 10.12968/hosp.2001.62.3.1535
  11. Anterior and lateral meningoceles

    Frazier J.. The Spina Bifida: Management and Outcome, 2008. doi: 10.1007/978-88-470-0651-5_35
  12. Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment

    van Dorst D.C.H.. Cardiovascular Drugs and Therapy, 2020. doi: 10.1007/s10557-020-07116-4
  13. Brazilian cardiology society statement for management of pregnancy and family planning in women with heart disease – 2020

    Avila W.S.. Arquivos Brasileiros de Cardiologia, 114 (5), 2020. doi: 10.36660/abc.20200406
  14. The Renin-Angiotensin System in the Central Nervous System and Its Role in Blood Pressure Regulation

    Nakagawa P.. Current Hypertension Reports, 22 (1), 2020. doi: 10.1007/s11906-019-1011-2
  15. Oral health-related quality of life in people with rare hereditary connective tissue disorders: Marfan syndrome

    Hanisch M.. International Journal of Environmental Research and Public Health, 15 (11), 2018. doi: 10.3390/ijerph15112382
  16. Abdominal aortic aneurysm: Sex differences

    Villard C.. Maturitas, 109 , 2018. doi: 10.1016/j.maturitas.2017.12.012
  17. Spinal Deformities in Marfan Syndrome

    Demetracopoulos C.A.. Orthopedic Clinics of North America, 38 (4), 2007. doi: 10.1016/j.ocl.2007.04.003
  18. Ruptured abdominal aortic aneurysm repair in pediatric Marfan syndrome patient

    Lu J.J.. Journal of Vascular Surgery Cases and Innovative Techniques, 4 (1), 2018. doi: 10.1016/j.jvscit.2017.11.008
  19. Inherited Thoracic Aortic Disease: New Insights and Translational Targets

    Fletcher A.J.. Circulation, 127 (19), 2020. doi: 10.1161/CIRCULATIONAHA.119.043756
  20. Chapter 8 Unusual Causes of Stroke

    Blecic S.. Blue Books of Practical Neurology, 29 , 2004. doi: 10.1016/S1877-3419(09)70083-2
  21. Full-mouth rehabilitation with implant-prosthesis in marfan syndrome patient: Clinical report and literature review

    Kutkut A.. Journal of Oral Implantology, 46 (2), 2020. doi: 10.1563/aaid-joi-D-19-00151
  22. Reactive oxygen species and oxidative stress in the pathogenesis and progression of genetic diseases of the connective tissue

    Egea G.. Antioxidants, 9 (10), 2020. doi: 10.3390/antiox9101013
  23. Syndromes with supernumerary teeth

    Lubinsky M.. American Journal of Medical Genetics, Part A, 127 (10), 2016. doi: 10.1002/ajmg.a.37763
  24. Dental development in children with supernumerary teeth in the anterior region of maxilla

    Mallineni S.. Clinical Oral Investigations, 23 (7), 2019. doi: 10.1007/s00784-018-2709-2
  25. Anterior sacral meningocoele presenting as acute urinary retention a case report

    Lefere M.. Acta Orthopaedica Belgica, 75 (6), 2009.
  26. Craniofacial characterization of Marfan Syndrome

    Johnson C.M.. Orthodontics and Craniofacial Research, 22 , 2019. doi: 10.1111/ocr.12295
  27. Neonatal Marfan syndrome: Report of two cases

    Jurko A.. Neuroendocrinology Letters, 38 (3), 2017.
  28. A comprehensive review of the literature and data analysis on hypo-hyperdontia

    Mallineni S.. Journal of Oral Science, 56 (4), 2014. doi: 10.2334/josnusd.56.295
  29. Management and outcomes of aortic dissection in pregnancy with marfan syndrome: A systematic review

    Al-Thani H.. Current Vascular Pharmacology, 18 (3), 2020. doi: 10.2174/1570161117666190408164612
  30. Efficacy and Complications of Palliative Irradiation in Three Scottish Fold Cats with Osteochondrodysplasia

    Fujiwara-Igarashi A.. Journal of Veterinary Internal Medicine, 29 (6), 2015. doi: 10.1111/jvim.13614
  31. Sudden Cardiac Death in Young Athletes: A Review

    McCaffrey F.M.. American Journal of Diseases of Children, 127 (2), 1991. doi: 10.1001/archpedi.1991.02160020069020
  32. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome

    Meester J.. Annals of Cardiothoracic Surgery, 6 (6), 2017. doi: 10.21037/acs.2017.11.03
  33. Intraoperative diagnosis of an anterior sacral meningocele mimicking a giant ovarian cyst in an adult

    Simsek H.. Vojnosanitetski Pregled, 75 (8), 2018. doi: 10.2298/VSP160508364S
  34. Pathogenic variants in THSD4, encoding the ADAMTS-like 6 protein, predispose to inherited thoracic aortic aneurysm

    Elbitar S.. Genetics in Medicine, 2020. doi: 10.1038/s41436-020-00947-4
  35. Mental deficiency and unstable bladder in a case of Marfan's syndrome

    Mavra M.. Medical Principles and Practice, 7 (1), 1998. doi: 10.1159/000026025
  36. A novel fibrillin-1 gene mutation leading to marfan syndrome in a Korean girl

    Nam H.. Annals of Clinical and Laboratory Science, 47 (2), 2017.
  37. A rare case of hypo-hyperdontia with thyroid disorder

    Peker I.. Cumhuriyet Dental Journal, 20 (1), 2017. doi: 10.7126/cumudj.307233
  38. Cardiac interventions and cardiac surgery and pregnancy

    Cauldwell M.. International Journal of Cardiology, 127 , 2019. doi: 10.1016/j.ijcard.2018.09.100
  39. Clinical characteristics and rate of dilatation in Turner syndrome patients treated for aortic dilatation

    Pater C.M.. American Journal of Medical Genetics, Part A, 127 (1), 2021. doi: 10.1002/ajmg.a.61931
  40. Bimaxillary concomitant hypohyperdontia in a 10-year-old child

    Kariya P.. BMJ Case Reports, 127 , 2017. doi: 10.1136/bcr-2017-220683
  41. Serum Vitamin C and spinal pain: A nationwide study

    Dionne C.E.. Pain, 127 (11), 2016. doi: 10.1097/j.pain.0000000000000671
  42. Ascher syndrome: A case report

    Üner D.. Nigerian Journal of Clinical Practice, 22 (7), 2019. doi: 10.4103/njcp.njcp_661_18
  43. Concomitant hypo-hyperdontia: A rare entity

    Wang Y.. Journal of Dental Sciences, 13 (1), 2018. doi: 10.1016/j.jds.2018.01.001
  44. Radicular dysfunction due to spinal deformities in Marfan syndrome at older age: Three case reports

    Voermans N.. European Journal of Medical Genetics, 53 (1), 2010. doi: 10.1016/j.ejmg.2009.10.006
  45. Characterization of the symptoms associated with dural ectasia in the Marfan patient

    Foran J.. American Journal of Medical Genetics, 127 (1), 2005. doi: 10.1002/ajmg.a.30525
  46. Mycotic aneurysms: Case reports in China and a review of the most current literature

    Yue Q.. International Journal of Clinical and Experimental Medicine, 10 (8), 2017.
  47. Pre-maxillary hypohyperdontia: a report of two cases

    Bowdin L.M.. European Archives of Paediatric Dentistry, 19 (2), 2018. doi: 10.1007/s40368-018-0329-9
  48. Diagnostic approach and management of genetic aortopathies

    Bhandari R.. Vascular Medicine (United Kingdom), 25 (1), 2020. doi: 10.1177/1358863X19886361
  49. Osteo-neuro-meningo-lombosacreal involvement in Marfan syndrome: One case

    Boyer A.. Journal des Maladies Vasculaires, 24 (2), 1999.
  50. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

    Regitz-Zagrosek V.. European Heart Journal, 39 (34), 2018. doi: 10.1093/eurheartj/ehy340
  51. Lumbar dural ectasia secondary to spinal fusion: A report of two cases

    Hong T.. Journal of Neuroimaging, 16 (4), 2006. doi: 10.1111/j.1552-6569.2006.00060.x
  52. Importance of dural ectasia in phenotypic assessment of Marfan's syndrome

    Fattori R.. Lancet, 127 (127), 1999. doi: 10.1016/S0140-6736(98)12448-0
  53. Rupture of a Type B Aortic Dissection in a Postpartum Patient with Marfan Syndrome

    Patberg E.. AJP Reports, 9 (3), 2019. doi: 10.1055/s-0039-1692712
  54. Marfan syndrome: Oral implication and management

    Bollero P.. ORAL and Implantology, 10 (2), 2017. doi: 10.11138/orl/2017.10.2.087
  55. Marfan Syndrome and Loeys-Dietz Syndrome in Children: A Multidisciplinary Team Experience

    Manchola-Linero A.. Revista Espanola de Cardiologia, 71 (7), 2018. doi: 10.1016/j.recesp.2017.03.023
  56. Sacral arachnoid cyst associated with marfan syndrome

    Hoshino Y.. Internal Medicine, 44 (3), 2005. doi: 10.2169/internalmedicine.44.271
  57. Interpretation of 2018 ESC Guidelines for Management of Cardiovascular Diseases during Pregnancy

    Zhang H.. Chinese General Practice, 21 (36), 2018. doi: 10.12114/j.issn.1007-9572.2018.00.351
  58. The Late Effects of Pregnancy on Aortic Dimensions in Patients with Marfan Syndrome

    Perelshtein Brezinov O.. Cardiology (Switzerland), 2020. doi: 10.1159/000511127
  59. Reliability of non-contrast magnetic resonance angiography-derived aortic diameters in Marfan patients: comparison of inner vs. outer vessel wall measurements

    Weinrich J.M.. International Journal of Cardiovascular Imaging, 36 (8), 2020. doi: 10.1007/s10554-020-01850-4
  60. Oral health in patients with Marfan syndrome

    Cervino G.. Archives of Oral Biology, 116 , 2020. doi: 10.1016/j.archoralbio.2020.104745
  61. Lumbo-peritoneal shunting improved spinal cord compression due to a large anterior sacral meningocele

    Rukskul P.. Journal of the Medical Association of Thailand, 88 (2), 2005.
  62. High-Risk Chief Complaints I: Chest Pain—The Big Three (an Update)

    Bautz B.. Emergency Medicine Clinics of North America, 38 (2), 2020. doi: 10.1016/j.emc.2020.01.009
  63. Chiari-like tonsillar herniation associated with intracranial hypotension in Marfan syndrome: Case report

    Puget S.. Journal of Neurosurgery, 106 (1), 2007.
  64. Sudden Cardiac Death in young athletes: How to identify patients at risk

    Del Rosario J.. Consultant, 36 (10), 1996.
  65. Deregulated microRNA and mRNA expression profiles in the peripheral blood of patients with Marfan syndrome

    Abu-Halima M.. Journal of Translational Medicine, 16 (1), 2018. doi: 10.1186/s12967-018-1429-3
  66. Unusual Supernumerary Teeth and Treatment Outcomes Analyzed for Developing Improved Diagnosis and Management Plans

    Chen K.C.. Journal of Oral and Maxillofacial Surgery, 77 (5), 2019. doi: 10.1016/j.joms.2018.12.014